Lucid Diagnostics Advances Multiple EsoGuard® and EsoCheck® Payment, Billing and Coding Pathways
PAVmed Inc PAVM
$3.82
▲ +0.53%
(+$0.02)
🎈 Low Float
Open
$3.83
Prev Close
$3.80
Day Range
$3.82 – $4.07
52W Range
$3.70 – $28.44
Market Cap
$30.50M
P/E (TTM)
76.17
Beta
0.89
EPS (TTM)
$-9.80
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2016-07-27 |
| Shares Out. | 7,160,000 |
| Website | pavmed.com/ ↗ |
| Phone | 12129494319 |
| Employees | 41 |
| Revenue | $33,000 |
| Gross Profit | -$89,000 |
| Net Income | -$6.6M |
| Free Cash Flow | -$7.8M |
| Total Assets | $40.2M |
| Total Liabilities | $20.9M |
| Equity | $19.3M |
About PAVmed Inc
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, EsoCheck, and the Veris Cancer Care Platform.
PAVmed Inc is a publicly traded company under the ticker symbol PAVM on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
8 analysts (2026-09-01)